Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- George Town, Grand Cayman, California
- Most recent report
- 8-K, filed Aug 25, 2026
- Incorporated
- California
- Filings on record
- 1,001+ filings
- On EDGAR
- CIK 1583107
- Fiscal year ends
- December
- Filer status
- Non-accelerated filer, Smaller reporting company
Financials 8 of 46
News 8 of 168
Prospectuses and Registrations 8 of 25
- S-8 Registration statement for an employee plan Mar 4, 2022
- 424B5 Prospectus supplement for an offering Jun 25, 2021
- 424B5 Prospectus supplement for an offering Jun 24, 2021
- S-8 Registration statement for an employee plan Mar 4, 2021
- S-3ASR Automatic shelf registration Sep 1, 2020
- S-8 Registration statement for an employee plan Mar 3, 2020
- 424B5 Prospectus supplement for an offering Feb 12, 2020
- 424B5 Prospectus supplement for an offering Feb 10, 2020
Proxies 8 of 22
- DEFA14A Extra proxy material Aug 25, 2026
- DEFM14A Aug 21, 2026
- PREM14A Aug 11, 2026
- DEFA14A Extra proxy material Jun 29, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 28, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 10, 2025
- DEF 14A Proxy statement for a shareholder vote Apr 5, 2024
- DEFA14A Extra proxy material Dec 21, 2023
Ownership 8 of 699
- 4 Insider reported a trade Aug 24, 2026
- 4 Insider reported a trade Aug 24, 2026
- 4 Insider reported a trade Aug 24, 2026
- 4 Insider reported a trade Aug 24, 2026
- 4 Insider reported a trade Aug 24, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Aug 14, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Aug 14, 2026
- 4 Insider reported a trade Jul 8, 2026
Other 8 of 41
Everything here comes from Theravance Biopharma, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.